Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Frontotemporal Lobar Degeneration
NCT00187525Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- May 2004
- Primary completion
- Oct 2005
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of memantine in Fronto-temporal lobar degeneration (FTLD), sponsored by University of California, San Francisco. Primary endpoint: Safety and Tolerability at 52 weeks. Started May 2004; status: completed.
02
Drugs
memantine
03
Conditions
Fronto-temporal lobar degeneration (FTLD)
Beyond the preview
Go deeper on NCT00187525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00187525.